In a new study, scientists discovered two FDA-approved cancer drugs that could also be effective at combatting one well-known ...

Researchers have identified special immune cells in the brain that help slow Alzheimer’s. These microglia work to reduce inflammation and block the spread of harmful proteins. They appear to protect ...

A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network ...

Researchers found that lecanemab, the Alzheimer’s drug designed to clear amyloid-β plaques, does not improve the brain’s waste clearance system in the short term.

The new treatment approach targets restoring normal blood vessel function instead of focusing on neurons or other brain cells, which has been the common strategy until now. A team of scientists co-led ...

A group from Osaka Metropolitan University in Japan, led by graduate student Tatsushi Oura and Dr. Hiroyuki Tatekawa, found ...

Boosting levels of a certain molecule that declines with age was found to restore memory and brain function in Alzheimer’s ...

Scientists have discovered a new target in the brain that could help prevent Alzheimer’s patients from losing memories of ...

Japanese researchers found that lecanemab, an amyloid-clearing drug for Alzheimer’s, does not improve the brain’s waste clearance system in the short term. This implies that nerve damage and impaired ...

People who inherit two copies of a gene variant called APOE4 have a 60% chance of developing Alzheimer's by age 85. Only about 2% to 3% of people in the U.S. have this genetic profile, and most of ...

The impact of Alzheimer’s Disease touches nearly all of us in some way. According to the Alzheimer’s Association, 1 in 9 ...